Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

With minimal blood loss and scarring, and faster recovery period, robotic surgeries are becoming game changers in the ...

Barry Stein had ignored symptoms that started appearing in 1995. Now he's committed to helping people recognize the signs of colorectal cancer.

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...

Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.

That will affect your treatment options and what you can expect -- or as doctors say, your prognosis. Both colon and rectal cancer affect the large intestine, which is the lowest part of the ...